Irregular heartbeat conditions affect millions of people worldwide, causing hearts to beat too fast, too slow, or with an uneven rhythm. These cardiac rhythm disturbances, medically known as ...
Trial findings challenge concerns over early rhythm control in patients with mild to moderate chronic kidney disease (CKD) and recent atrial fibrillation.
CHICAGO, IL (updated) — Either strategy may be more appropriate in individual patients, but overall, atrial fibrillation developing after heart surgery responds similarly to either rate-control or ...
New research explains how low levels of the electrolyte sodium in the blood can disrupt the timing of the heartbeat in patients taking widely used rhythm-control medications such as flecainide, which ...
Omaha, NE - The results of a recent study have shown a trend toward a lower rate of early atrial fibrillation (AF) recurrence at 24 hours after direct-current (DC) cardioversion in patients receiving ...
Some proven agents recommended for rhythm control in AF include amiodarone, dofetilide, flecainide, propafenone, sotalol, and a newly released medication called dronedarone. 4 Recommended dosages, ...
New research explains how low levels of the electrolyte sodium in the blood can disrupt the timing of the heartbeat in patients taking widely used rhythm-control medications such as flecainide, which ...
Researchers at Ben-Gurion University of the Negev (BGU) have identified how two different classes of medication—the GLP-1 receptor agonist semaglutide and the anti-inflammatory drug colchicine—act on ...
Steven Poelzing (left) and Gregory Hoeker, researchers at the Fralin Biomedical Research Institute at VTC, collaborated on a new study published in the journal Heart Rhythm revealing why low blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results